Transforming one-off therapies into accessible and repeatable programs requires early strategy and shared infrastructure.

An in-body networking system allows communication between wearable and implantable therapeutics using signals transmitted through the body's own tissues.

Gut microbiome development in children at high genetic risk of type 1 diabetes follows three distinct maturation patterns ...

Researchers discovered why some CAR T therapy patients develop severe intestinal inflammation and a repurposed oral inhibitor ...

Danegaptide could offer a new way to prevent or slow vision-threatening damage caused by diabetic retinopathy.

Ultra-processed food is linked with multiple chronic disease outcomes with each 100g contributing to an increase in risk, a meta-analysis involving more than eight million people suggests.

A new study reveals how an IL-21 mimic harnesses CD4 T cells to turn transient KRAS inhibitor responses into durable ...

A study looking at 920 chemicals linked to breast cancer risk shows many are ubiquitous in the environment and in many ...

EASD 2026 findings show cancer incidence remains higher in people with type 2 diabetes, with the gap widening over 25 years, ...

Beacon Therapeutics reports positive results in its Phase II/III trial of its gene therapy for treatment of X-linked retinitis pigmentosa.